Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Clinical Research

Low serum neutrophil count predicts a positive prostate biopsy

Abstract

Background:

Asymptomatic prostatic inflammation may cause increased PSA in some men, leading to unnecessary prostate biopsy. We investigated whether the differential white cell count could predict the result of prostate biopsy.

Methods:

Prostate needle biopsy was carried out in 323 Japanese men with elevated PSA levels or abnormal digital rectal findings. White blood cell count (WBC), differential white cell count (neutrophils, lymphocytes, basophils, eosinophils, and monocytes), and serum C-reactive protein level were assessed for associations with biopsy findings.

Results:

In all, 203 (62.1%) were positive for prostate cancer. WBC, neutrophil count, age, PSA, prostate volume, and PSA density (PSAD) were associated with the results of biopsy (P<0.05). Multivariate analysis showed that neutrophil count, age, PSA, prostate volume and PSAD were independent predictors. When the cut-off neutrophil count was set at 2900 μl−1, 78 of 104 men (75.0%) with a count below this value had a positive biopsy, while 125 of 219 (57.0%) men with a count above this value were positive. The area under the receiver-operator characteristics curve (AUC) for the predicted probability of a positive biopsy for prostate cancer according to the optimum logistic model was 0.83 (95% confidence interval (CI) 0.78–0.87), while the AUC for PSA was 0.70 (95% CI 0.64–0.76) and that for PSAD was 0.79 (95% CI 0.74–0.84).

Conclusions:

An elevated neutrophil count may be a good indicator of a benign prostate biopsy. Men with a low neutrophil count and an increase of serum PSA should strongly be considered for biopsy.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Deras IL, Aubin SM, Blase A, Day JR, Koo S, Partin AW et al. PCA3: a molecular urine assay for predicting prostate biopsy outcome. J Urol 2008; 179 (4): 1587–1592.

    Article  PubMed  Google Scholar 

  2. Thompson IM, Ankerst DP, Chi C, Goodman PJ, Tangen CM, Lucia MS et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 2006; 98 (8): 529–534.

    Article  PubMed  Google Scholar 

  3. Schatteman PH, Hoekx L, Wyndaele JJ, Jeuris W, Van Marck E . Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density. Eur Urol 2000; 37 (4): 404–412.

    Article  CAS  PubMed  Google Scholar 

  4. Kandirali E, Boran C, Serin E, Semercioz A, Metin A . Association of extent and aggressiveness of inflammation with serum PSA levels and PSA density in asymptomatic patients. Urology 2007; 70 (4): 743–747.

    Article  PubMed  Google Scholar 

  5. Fujita K, Hosomi M, Tanigawa G, Okumi M, Fushimi H, Yamaguchi S . Prostatic inflammation detected in initial biopsy specimens and urinary pyuria are predictors of negative repeat prostate biopsy. J Urol 2011; 185 (5): 1722–1727.

    Article  PubMed  Google Scholar 

  6. Okada K, Kojima M, Naya Y, Kamoi K, Yokoyama K, Takamatsu T et al. Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer. Urology 2000; 55 (6): 892–898.

    Article  CAS  PubMed  Google Scholar 

  7. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007; 7 (4): 256–269.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Mengus C, Le Magnen C, Trella E, Yousef K, Bubendorf L, Provenzano M et al. Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer. J Transl Med 2011; 9: 162.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Beer TM, Lalani AS, Lee S, Mori M, Eilers KM, Curd JG et al. C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial. Cancer 2008; 112 (11): 2377–2383.

    Article  CAS  PubMed  Google Scholar 

  10. Terakawa T, Miyake H, Kanomata N, Kumano M, Takenaka A, Fujisawao M . Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10–50 ng/ml. Urology 2008; 72 (6): 1194–1197.

    Article  PubMed  Google Scholar 

  11. Nonomura N, Takayama H, Kawashima A, Mukai M, Nagahara A, Nakai Y et al. Decreased infiltration of macrophage scavenger receptor-positive cells in initial negative biopsy specimens is correlated with positive repeat biopsies of the prostate. Cancer Sci 2010; 101 (6): 1570–1573.

    Article  CAS  PubMed  Google Scholar 

  12. Karakiewicz PI, Benayoun S, Kattan MW, Perrotte P, Valiquette L, Scardino PT et al. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J Urol 2005; 173 (6): 1930–1934.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kato T, Suzuki H, Komiya A, Imamoto T, Naya Y, Tobe T et al. Clinical significance of urinary white blood cell count and serum C-reactive protein level for detection of non-palpable prostate cancer. Int J Urol 2006; 13 (7): 915–919.

    Article  CAS  PubMed  Google Scholar 

  14. Sfanos KS, De Marzo AM . Prostate cancer and inflammation: the evidence. Histopathology 2012; 60: 199–215.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Cheng I, Witte JS, Jacobsen SJ, Haque R, Quinn VP, Quesenberry CP et al. Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men's Health Study. PLoS One 2010; 5 (1): e8736.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Fridlender ZG, Albelda SM . Tumor-associated neutrophils: friend or foe? Carcinogenesis 2012; 33 (5): 949–955.

    Article  CAS  PubMed  Google Scholar 

  17. Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN. Cancer Cell 2009; 16 (3): 183–194.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Kramer G, Marberger M . Could inflammation be a key component in the progression of benign prostatic hyperplasia? Curr Opin Urol 2006; 16 (1): 25–29.

    PubMed  Google Scholar 

  19. Fukami A, Yamagishi S, Adachi H, Matsui T, Yoshikawa K, Ogata K et al. High white blood cell count and low estimated glomerular filtration rate are independently associated with serum level of monocyte chemoattractant protein-1 in a general population. Clin Cardiol 2011; 34 (3): 189–194.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Fujita K, Ewing CM, Getzenberg RH, Parsons JK, Isaacs WB, Pavlovich CP . Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia. Prostate 2010; 70 (5): 473–481.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. The Committee for Establishment of the Guidelines on Screening for Prostate Cancer, Association JU. Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010. Int J Urol 2010; 17: 830–838.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K Fujita.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fujita, K., Imamura, R., Tanigawa, G. et al. Low serum neutrophil count predicts a positive prostate biopsy. Prostate Cancer Prostatic Dis 15, 386–390 (2012). https://doi.org/10.1038/pcan.2012.27

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/pcan.2012.27

Keywords

This article is cited by

Search

Quick links